Possible contributing factors include insecticide resistance in the primary malaria vector, the COVID-19 pandemic, the emergence of the HRP2/3 deletion, deterioration of the healthcare system, internal conflicts and invasion by the exotic malaria vector, Anopheles stephensi [14–17]. The gene discussed is HDGFL2; the disease is malaria.